Global investment firm Carlyle has agreed to sell its entire investment in Sunsho Pharmaceutical, a Japanese contract manufacturer of health and nutrition products, to Osaka-based Towa Pharmaceutical.
The financial details of the deal were not disclosed. Carlyle said in a statement that the transaction is expected to be completed in February next year.
